| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698580 | Clinical Oncology | 2015 | 5 Pages |
Abstract
D90 values of less than 140Â Gy continue to be predictive of increased risk of recurrence of prostate cancer across risk groups with longer follow-up. Quality assurance can be used to ensure improved and consistent implant quality in a team with multiple clinicians.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.M. Henry, S.L. Rodda, M. Mason, H. Musunuru, B. Al-Qaisieh, P. Bownes, J. Smith, K. Franks, B. Carey, D. Bottomley,